Leibniz-Forschungsinstitut für Molekulare Pharmakologie

Leibniz-Forschungsinstitut für Molekulare Pharmakologie

The Leibniz-Forschungsinstitut für Molekulare Pharmakologie is a research institute in the Leibniz Association, focussing on proteins as basic structures of cellular organisms. It is one of the large number of research institutions based in Berlin. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Germany, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

63%


Total
Publications

2.5K


Total Open
Publications

1.6K


Total
Citations

111K


Open Access
Percentage

63%


Total
Publications

2.5K


Total Open
Publications

1.6K


Total
Citations

111K

Wikipedia

Website

download

Breakdown

16% 33% 14% 37%

Publisher Open

16%

Both

33%

Other Platform Open

14%

Closed

37%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

46%OA Journal

OA Journal 46%

561

Hybrid 25%

306

No Guarantees 29%

361

Other Platform Open

Domain 63%

743

Institution 57%

670

Other Internet 18%

214

Preprint 15%

175

Public 4%

45

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
756
doaj.org OAI-PMH Repository
Institution
247
DOI
Other Internet
187
bioRxiv
Preprint
148
ZB MED - Information Centre for Life Sciences
Institution
137
Max Planck Society
Institution
83
Freie Universität Berlin
Institution
73
Unknown Repository
Other Internet
53
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
44
Asklepios Klinik St. Georg
Institution
39
1 / 17

Data updated 12 August 2026

Share

Share

Share